|
Small molecules |
Biologicals |
Process development |
- Starting materials selection and justification
|
- Cell line development (vector design, host and clone selection)
|
- Active pharmaceutical ingredient (API) synthetic processes
|
- Upstream processing (cell culture, fermentation)
|
- Drug product process development
|
- Downstream processing (purification, intermediate and drug substance storage)
|
|
- Validation of process clearance (including viral validation)
|
|
- Drug product process development (liquid, frozen, and lyophilized; containers and devices)
|
Formulation development |
|
- Product tolerance ranges (pH, buffers, salts, surfactants, temperature, etc.)
|
- Compounding, tableting, and capsulation
|
- Product formulation (API/drug substance and drug product)
|
|
- Device and delivery system compatibility
|
- Device and delivery system compatibility
|
|
Analytical development |
- Product characterization (chemical, biochemical, immunochemical, and biophysical)
|
- Analytical method development (in-process, lot release, and stability testing)
|
Manufacturing and Testing (preclinical [GLP] and CGMP) |
- Technical review/audit of manufacturing and testing facilities
|
|
|
|
- Reference standard production, testing, and management
|
- Analytical method transfer, qualification and validation
|
- Quality Control (QC) testing
|
- Stability program design and implementation (process intermediates, API/drug substance, drug product)
|
- Analytical support of investigations (nonconformances, out-of-specification and out-of-trend [OOS/OOT] results)
|
- Comparability protocol design and execution (process and analytical method changes)
|